title: Will oral rivaroxaban improve clinically relevant outcomes and thromboprophylaxis management in the orthopedic patient?
authors.forename: A
authors.initials: A
authors.lastname: Gómez-Outes
authors.forename: M L
authors.initials: ML
authors.lastname: Suárez-Gea
authors.forename: A
authors.initials: A
authors.lastname: Blázquez-Pérez
authors.forename: C
authors.initials: C
authors.lastname: Pozo-Hernández
authors.forename: E
authors.initials: E
authors.lastname: Vargas-Castrillón
mesh_terms: D006801:Humans; D009025:Morpholines / Q000008:administration & dosage*; D009985:Orthopedics; D011183:Postoperative Complications / Q000517:prevention & control; D011292:Premedication; D000069552:Rivaroxaban; D013876:Thiophenes / Q000008:administration & dosage*; D013927:Thrombosis / Q000517:prevention & control*; D016896:Treatment Outcome
chemical_list: D009025:Morpholines; D013876:Thiophenes; D000069552:Rivaroxaban